(Q31089069)

28 June 2017

1 reference

title

Anakinra treatment of patients with rheumatoid arthritis (English)

1 reference

28 June 2017

1 reference

1 reference

1

Leonard H Calabrese

1 reference

PubMed ID

12086555

28 June 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

Annals of Pharmacotherapy

28 June 2017

1 reference

28 June 2017

36

1 reference

28 June 2017

1204-1209

1 reference

28 June 2017

7-8

1 reference

Non-steroidal anti-inflammatory drugs and gastrointestinal damage-problems and solutions

28 June 2017

1 reference

Treatment options for rheumatoid arthritis: celecoxib, leflunomide, etanercept, and infliximab

21 January 2018

1 reference

Anti-tumor necrosis factor therapies

21 January 2018

1 reference

Treatment of rheumatoid arthritis with recombinant human interleukin-1 receptor antagonist.

21 January 2018

1 reference

A multicenter, double-blind, dose-ranging, randomized, placebo-controlled study of recombinant human interleukin-1 receptor antagonist in patients with rheumatoid arthritis: radiologic progression and correlation of Genant and Larsen scores

21 January 2018

1 reference

Leflunomide and rheumatoid arthritis: a systematic review of effectiveness, safety and cost implications

21 January 2018

1 reference

Physiology of cytokine pathways in rheumatoid arthritis

21 January 2018

1 reference

Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis

21 January 2018

1 reference

Interleukin-1 receptor antagonist: role in biology

21 January 2018

1 reference

Interleukin 1 receptor antagonist. A new member of the interleukin 1 family

21 January 2018

1 reference

Inhibition of interleukin 1 (IL-1) binding and bioactivity in vitro and modulation of acute inflammation in vivo by IL-1 receptor antagonist and anti-IL-1 receptor monoclonal antibody

21 January 2018

1 reference

Etanercept therapy in rheumatoid arthritis. A randomized, controlled trial.

21 January 2018

1 reference

Infliximab (chimeric anti-tumour necrosis factor alpha monoclonal antibody) versus placebo in rheumatoid arthritis patients receiving concomitant methotrexate: a randomised phase III trial. ATTRACT Study Group

21 January 2018

1 reference

Infliximab and methotrexate in the treatment of rheumatoid arthritis. Anti-Tumor Necrosis Factor Trial in Rheumatoid Arthritis with Concomitant Therapy Study Group

21 January 2018

1 reference

Tumour necrosis factor α stimulates resorption and inhibits synthesis of proteoglycan in cartilage

21 January 2018

1 reference

21 January 2018

Identifiers

DOI

10.1345/APH.1A396

1 reference

28 June 2017

1 reference

PubMed ID

12086555